Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
---|
03/21/1996 | CA2199048A1 Anaesthetic analgesic gas mixtures containing enflurane or isoflurane in combination with sevoflurane or desflurane |
03/21/1996 | CA2198900A1 Intermediates for dinucleotide and oligonucleotide analogues |
03/21/1996 | CA2198478A1 Fibrinogen receptor antagonists |
03/21/1996 | CA2198361A1 Intracellular delivery of chemical agents to a specific cell type |
03/21/1996 | CA2198019A1 Triazolopyridazines process and intermediates for their preparation and their use as medicaments |
03/21/1996 | CA2196064A1 4-(4-methanesulfonamidophenyl)butylamine derivatives with antiarrhythmic activity |
03/21/1996 | CA2176011A1 Anti-hiv drug |
03/21/1996 | CA2158724A1 Transdermally active pharmaceutical composition containing 5-aminolaevulinic acid |
03/20/1996 | EP0702084A1 Recombinant retroviruses |
03/20/1996 | EP0702026A2 Modified bile acids, a process for their production and their use |
03/20/1996 | EP0702015A1 Bicyclic oxazole and thiazole substituted ethers |
03/20/1996 | EP0702013A2 Imidazopyridines |
03/20/1996 | EP0702012A1 Substituted isoxazole sulfonamides and their use as endothelin antagonists |
03/20/1996 | EP0702010A1 Benzopyranderivatives, process for their preparation and pharmaceutical compositions containing them |
03/20/1996 | EP0702009A1 Method for the preparation of 3-hydroxy-5-(2-(dimethylamino)-ethy1)-2,3-dihydro-4-(methoxyphenyl)-1,5-benzothiazepin-4(5H)-one and use of the product for making pharmaceutically active compounds |
03/20/1996 | EP0702004A2 2,9-diamino- and 2-amino-8-carbamoyl-4-hydroxy-alkanoic acid amid derivatives |
03/20/1996 | EP0702001A1 Fluoro-alkyl/alkenyl-substituted benzoylguanidinens and their use as medicament or diagnostic agent |
03/20/1996 | EP0701991A1 Process for the preparation of lignin analogues and starting materials therefor |
03/20/1996 | EP0701988A1 Substituted cyclopentane-di- and triones, their preparation and their use as chloride channel blockers |
03/20/1996 | EP0701819A2 Novel compositions containing sertraline and a 5-HT1D receptor agonist or antagonist |
03/20/1996 | EP0701818A2 Therapeutic methods using catalytic antibodies |
03/20/1996 | EP0701817A2 Medicaments for treating vascular leak syndrome |
03/20/1996 | EP0701816A2 Percutaneous absorption preparation containing isosolide dinitrate |
03/20/1996 | EP0701609A1 Inhibition of proliferation of vascular smooth muscle cell |
03/20/1996 | EP0701606A1 Method of enhancing thrombolysis |
03/20/1996 | EP0701568A1 New peptide derivatives |
03/20/1996 | EP0701565A1 New prednisolone derivates |
03/20/1996 | EP0701564A1 Bifunctional nucleosides, oligomers thereof, and methods of making and using the same |
03/20/1996 | EP0701563A1 Gene transfer for treating a connective tissue of a mammalian host |
03/20/1996 | EP0701560A1 Bicyclic ether derivatives and their use as 5-lipoxygenase inhibitors |
03/20/1996 | EP0701559A1 Cephalostatin analogues and their use as anti-tumour agents |
03/20/1996 | EP0701557A1 Lavendamycin analogs, their use and preparation |
03/20/1996 | EP0701555A1 Indazole derivatives |
03/20/1996 | EP0701554A1 Novel compounds having a benzisoselen-azoline and -azine structure, method for preparing same and therapeutic uses thereof |
03/20/1996 | EP0701553A1 Arylpyrazole fungicides |
03/20/1996 | EP0701546A1 Aromatic acetylcholinesterase inhibitors |
03/20/1996 | EP0701455A1 Plasma-like solution |
03/20/1996 | EP0701450A1 Recombinant viruses and their use in gene therapy |
03/20/1996 | EP0701449A1 Process for the preparation of an oral solid dosage form containing diclofenac |
03/20/1996 | EP0701448A1 Amplification of the vitamin b 12? uptake system using polymers |
03/20/1996 | EP0701445A1 Agents containing a compound with an anti-androgen effect and a compound with a competitive, progesterone-antagonistic effect |
03/20/1996 | EP0701444A1 Methods and compositions for inducing sleep |
03/20/1996 | EP0701443A1 Terfenadine metabolites and their optically pure isomers for treating allergic disorders |
03/20/1996 | EP0701442A1 New use of ambasilide |
03/20/1996 | EP0701441A1 Alkaline and acid phosphatase inhibitors in treatment of neurological disorders |
03/20/1996 | EP0701440A1 Tri(platinum) complexes |
03/20/1996 | EP0701439A1 Stable copper(i) complexes and methods related thereto |
03/20/1996 | EP0701438A1 Gaba-ergic modulation of eye growth |
03/20/1996 | EP0701434A1 Preparations containing silicon dioxide to improve the taste thereof |
03/20/1996 | EP0690867A4 Taxanes having furyl or thienyl substituted side-chain |
03/20/1996 | EP0690711A4 Taxanes having an amino substituted side-chain |
03/20/1996 | EP0688212A4 C9 taxane derivatives and pharmaceutical compositions containing them |
03/20/1996 | EP0659083A4 Prevention and treatment of peripheral neuropathy. |
03/20/1996 | EP0656776B1 Multilayer controlled release tablets containing both naproxen and naproxen sodium salt |
03/20/1996 | EP0638584B1 5-o-desosaminylerythronolide a derivative |
03/20/1996 | EP0586490B1 Derivatives of perhydroisoindol, their preparation, and pharmaceutical compositions containing them |
03/20/1996 | EP0561820B1 Control of parasitic nematodes |
03/20/1996 | EP0556332B1 Substituted tetrahydropyridines and hydroxypiperidines as central nervous system agents |
03/20/1996 | EP0540670B1 Method for preparation of crosslinked polyamines |
03/20/1996 | EP0505465B1 4-Heterocyclyl-piperidine derivatives, their preparation and their use as inhibitors of calcium overload in brain cells |
03/20/1996 | EP0489072B1 Treatment of chronic inflammatory conditions |
03/20/1996 | EP0482108B1 Substituted 2-imidazolines and preparation and use thereof |
03/20/1996 | EP0449973B1 Polypeptide-polymer conjugates active in wound healing |
03/20/1996 | EP0417281B1 COMPOSITION CONTAINING 5$g(a)-DIHYDRO-19-NORETHYSTERONE AND ITS DERIVATIVES CAPABLE OF INHIBITING AROMATASE IN VIVO |
03/20/1996 | EP0389521B1 2',5'-phosphorothioate oligoadenylates and antiviral uses thereof |
03/20/1996 | CN2222535Y Compound oral capsule |
03/20/1996 | CN1119019A Compositions and methods for the treatment of immunomediated inflammatory disorders |
03/20/1996 | CN1119017A Oligodeoxynucleotides containing 5-alkyl-,5(1-alkenyl)- and 5-(1-alkynyl)pyrimidines and pharmaceutical compositions containing such compounds |
03/20/1996 | CN1119016A Crystalline ceftiofur free acid |
03/20/1996 | CN1119014A Benzopyranes as potassium channel openers |
03/20/1996 | CN1119013A Hydroxymethyl furazane carboxylic acid derivatives and their use in the treatment of cardio-vascular conditions |
03/20/1996 | CN1118991A Interleukin-1 inhiBitor |
03/20/1996 | CN1118990A Medicament for treating or preventing cerebrovascular diseases |
03/20/1996 | CN1118989A Pharmaceutical compositions comprising paracetamol and L-cysteine or a precursor thereof |
03/20/1996 | CN1118988A Sugar- and sodium-free effervescent tablets and granules and process for preparing same |
03/20/1996 | CN1118785A Magnesium gluconate for medicine use and its preparation method for oral liquor |
03/20/1996 | CN1118783A A process for preparing novel pyrido (3,2-B)(1,5) benzothiazepines |
03/20/1996 | CN1118782A Cyclohexan-derivative, preparation and application for treatment of same |
03/20/1996 | CN1118781A Heterocyclic compound with activity against diabetes and preparation and application of same |
03/20/1996 | CN1118780A Application of derivative of nitrogen hetero-spiro alkyl |
03/20/1996 | CN1118689A Medicine for curing silkworm diseases and its preparing and using method |
03/20/1996 | CN1118688A Method for slowing progression of coronary artery atherosclerosis employing pravastation |
03/20/1996 | CN1118687A Synergy norfloxacin drinking agent |
03/20/1996 | CN1031342C Process for preparing 1,5-benzothiazepine derivatives |
03/20/1996 | CN1031339C Process for preparation of heterocyclically substituted phenylacetic acid derivatives |
03/20/1996 | CA2158517A1 Aminomethylphosphonic and aminomethylphosponic acid derivates and their use for treating degenerative joint disorders |
03/20/1996 | CA2158076A1 Antitumor antibiotic compounds; hayumicins and analogs thereof |
03/19/1996 | US5500807 Selection method for pharmacologically active compounds |
03/19/1996 | US5500448 Applying triclosan to ulcers |
03/19/1996 | US5500445 Intraocular irrigating and enucleated eyeball preservative composition |
03/19/1996 | US5500443 New benzodioxane compounds |
03/19/1996 | US5500442 Cyclobut-3-ene-1,2-dione derivatives as smooth muscle relaxants |
03/19/1996 | US5500439 Food preservative, discoloration inhibition for teeth, glycosylation inhibition |
03/19/1996 | US5500436 2-(N-(2-aminomethyl)amino)acetic acid derivatives to inhibit advanced glycosylation |
03/19/1996 | US5500435 Benzimidazoles and benzotriazoles, treatment of retinoid sensitive skin disorders |
03/19/1996 | US5500434 Mixture of trandolapril and felodipine |
03/19/1996 | US5500430 Amidic derivatives of glutamic, aspartic and 2-amino adipic acids, a process for preparing same, and anti-gastrin composition containing the derivatives |
03/19/1996 | US5500429 Cardiovascular |
03/19/1996 | US5500428 Furyl-substituted purines and adenosine antagonists |
03/19/1996 | US5500426 Administered to improve glucose tolerance |